Access to antiretroviral drugs and AIDS management in Senegal

AIDS

Volumn 17, Issue SUPPL. 3, 2003, Pages

  Desclaux, Alice ^a   Ciss, Mounirou ^b   Taverne, Bernard ^c   Sow, Papa S ^d   Egrot, Marc ^a   Faye, Mame A ^d   Lanièce, Isabelle ^e   Sylla, Omar ^e   Delaporte, Eric ^f   Ndoye, Ibrahima ^e  

^a AIX MARSEILLE UNIVERSITY   (France)

^b Ministry of Health   (Senegal)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^d Thoracic and Cardiovascular Surgery Clinic   (Senegal)

^e National AIDS Program   (Senegal)

^f UNIV MONTPELLIER   (France)

Author keywords

Access; Africa; Antiretroviral; Highly active antiretroviral therapy; HIV; Public health; Senegal

Indexed keywords

ABACAVIR; ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZERIT 40; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; ECONOMIC ASPECT; FEASIBILITY STUDY; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT SELECTION; PHARMACIST; PRIORITY JOURNAL; RESEARCH; SENEGAL; SOCIAL ASPECT; SOCIAL WORKER; SUPPORT GROUP;

EID: 0042128310     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200317003-00013     Document Type: Article

References (20)

1. Kallings LO, Vella S. Access to HIV/AIDS care and treatment in the South of the world. AIDS 2001; 15:IAS1-IAS3.
2. International AIDS Society. Consensus report. Place of antiretroviral drugs in the treatment of HIV-infected people in Africa. AIDS 1999; 13:IAS1-IAS3.
3. Africa. Use of Antiretroviral Drugs in the Management of HIV-infected Persons. Updated Recommendations, October 2000. Paris:ANRS, IMEA, IRD, Société africaine contre le sida, UNAIDS, PNLS-Sénégal, PNLS-Côte-d'Ivoire, International AIDS Society.
4. de Vincenzi I. How to simplify and adapt antiretroviral combination therapy and monitoring for use in low and middle income countries. Geneva: MSF; 2001.
5. Adams G, Addo M, Aldouini A, Alkfeld M, Anderson D, Carswell KA, et al. Consensus Statement on ART for AIDS in Poor Countries by Individual Members of the Faculty of Harvard University. Harvard: Boston. 2001.
6. WHO. WHO International Consultative Meeting on HIV/AIDS Antiretroviral Therapy. Report of the Meeting. Geneva, 22-23 May 2001. Geneva: WHO; 2001.
7. Desclaux A, Lanièce I, Ndoye I, Taverne B, (eds). L'initiative sénégalaise d'accès aux médicaments antirétroviraux. Analyses économiques, sociales, comportementales et médicales. Paris: ANRS; 2002.
8. Lanièce I, Ciss M, Desclaux A, Diop K, Mbodj F, Ndiaye B, et al. Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS 2003: 17(suppl 3):S103-S108.
9. Vergne L, Touré Kane C, Laurent C, Diakhaté N, Ngom NF, Gueye M, et al. Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese Government Initiative of access to anti-retroviral treatment. AIDS 2002; XXX [ED: this issue]
10. UNAIDS. Acting early to prevent AIDS: The case of Senegal. Best Practices, UNAIDS/99. 34E. Geneva: UNAIDS; 1999.
11. Laurent C, Diakhaté N, Ngom Gueye NF, Toure MA, Sow PS, Faye MA, et al. The Senegalese government's HAART intiative: an 18-month follow-up study of feasibility, effectiveness, adherence, toxicity and viral resistance. AIDS 2002; 16:1363-1370.
12. Ciss M, Vinard P, Diop K. Le système d'approvisionnement et de financement des ARV. In: Desclaux A, Lanièce I, Ndoye I, Taverne B (editors): L'Initiative sénégalaise d'accès aux médicaments antirétroviraux. Analyses économiques, sociales, comportementales et médicales. Paris: ANRS; 2002. pp. 67-78.
13. Canestri A, Taverne B, Thiam S, Laurent C, Ndir A, Schiemann R, Landmann R. Coûts directs du suivi médical à la charge des patients hors antirétroviraux. In: Desclaux A, Lanièce I, Ndoye I, Taverne B (editors): L'Initiative sénégalaise d'accès aux médicaments antirétroviraux. Analyses économiques, sociales, comportementales et médicales. Paris: ANRS; 2002. pp. 55-66.
14. Gomes (do Espirito Santo) E. Étude sur l'équité dans l'accès aux soins de santé et les déterminants socio-économiques des recours aux soins dans la région de Dakar. Dakar: Ministère de la Santé, Fnuap, Service de coopération et d'action culturelle; 2000.
15. Geest (Van der) S, Reynolds-Whyte S (eds). The Context of Medicines in Developing Countries. Studies in Pharmaceutical Anthropology. Dordrecht/Boston/London: Kluwer Academic Publishers; 1998. 392 pp.
16. Fassin D. Pouvoir et maladie en Afrique. Paris: PUF, Les Champs de la Santé; 1992. 359 pp.
17. Werner JF. Marges, sexe et drogues à Dakar. Enquête ethnographique. Paris: Karthala-Orstom; 1993. 292 pp.
18. Egrot M, Taverne B, Ciss M, Ndoye I. La circulation des médicaments antirétroviraux au Sénégal. In: Desclaux A, Lanièce I, Ndoye I, Taverne B (editors): L'Initiative sénégalaise d'accès aux médicaments antirétroviraux. Analyses économiques, sociales, comportementales et médicales. Paris: ANRS; 2002. pp. 221-231.
19. Health, a key to prosperity. Success stories in developing countries. Senegal contains the spread of HIV. http://www.who.int/inf-new/aids3.htm
20. United Nations. Resolution adopted by the General Assembly, August 2001. A/RES/S-26/2. New York: UN 2001.